Links of interest
Laboratory’s website: http://www.pcanlab.ca
https://www.mcgill.ca/neuro/article/three-burning-questions-dr-oury-monchi
Monchi Oury
Ph.D.
Scientific Director of CRIUGM
Contact information
Research Centre, IUGM
4545 Queen Mary Road
Montreal, Quebec
Canada H3W 1W5
Office : M7804
(514) 340-3540 #4710
oury.monchi@umontreal.ca
Biography
Oury Monchi obtained his Ph.D. in Computational Neuroscience at King’s College London, UK. He then pursued postdoctoral fellowships at the Montreal Neurological Institute, and at the Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal (CRIUGM) in neuroimaging applied to Parkinson’s disease. Until the summer of 2014 he was Associate Professor of Radiology at the Université de Montréal and a scientist at the CRIUGM. From 2014 to 2021 Prof. Monchi was Professor and director for clinical research at the department of Clinical Neurosciences at the University of Calgary. During that time, he held the Canada Research Chair (Tier 1) in non-motor symptoms of Parkinson’s disease and the Tourmaline Oil Chair in Parkinson’s disease. Since 2018, he is the director of the Canadian-Open Parkinson Network, a platform funded by Brain-Canada and Parkinson Canada. Since November 2021, Prof. Monchi is the Scientific Director of the Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal and Full Professor of Radiology, Radio-oncology and Nuclear Medecine at the Université de Montréal.
Research interests
Prof. Monchi’s lab has been a pioneer in using different neuroimaging techniques to study the origins and evolution of non-motor
(including cognitive and neuropsychiatric) deficits in Parkinson’s disease with the ultimate goal of the early prediction of dementia in the disease. Non-medication therapies such as transcranial magnetic stimulation and low intensity focused ultrasound are also being explored. Methods used include functional and anatomical MRI, TMS, LiFU, neuropsychological and neuropsychiatric evaluations, genotyping and machine learning. Collaborations are on their way with the lab of Prof. Pierre Rainville to charectirise various pain profiles in Parkinson’s disease.
